Back to VANGUARD GROUP INC VANGUARD GROUP INC

BBIOBBIO
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in BRIDGEBIO PHARMA INC

VANGUARD GROUP INC holds 16.9M shares of BBIO (BRIDGEBIO PHARMA INC), worth $1.3B as of 2025-Q4. The position was increased (+0.2% shares). BBIO represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$1.3B

Current Shares

16.9M

Total Value Change

+$928.3M

Total Shares Change

+2.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
16.9M
+0.2%
$1.3B0.0%$75.48
32
2025-Q3
Increased
16.8M
+2.1%
$874.3M0.0%$51.96
32
2025-Q2
Increased
16.5M
+10.6%
$711.8M0.0%$44.86
35
2025-Q1
Decreased
14.9M
-1.2%
$515.1M0.0%$35.11
0
2024-Q4
Increased
15.1M
+6.2%
$413.7M0.0%$27.32
33
2024-Q3
New
14.2M
-
$361.5M0.0%$24.94
43

Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used